Thomas Wagner

Papers

Total Citations

H-Index

About

Thomas Wagner is a leading urological oncologist whose research focuses on the surgical management of testicular cancer, particularly non-seminomatous germ cell tumours. His major contributions center on refining post-chemotherapy retroperitoneal lymph node dissection (RPLND), a complex procedure critical for patients with residual retroperitoneal masses. In his highly cited 2021 systematic review, Wagner comprehensively analyzed oncological outcomes and complications of this surgery, providing essential benchmarks for recurrence rates and surgical morbidity. This work has helped standardize treatment protocols and improve patient selection for bilateral versus unilateral RPLND. With over 14 citations in a short time, his research is widely referenced by surgeons and oncologists navigating the delicate balance between curative resection and preservation of quality of life. Wagner’s scholarship is notable for its rigorous synthesis of evidence, directly impacting clinical decision-making in high-volume testicular cancer centers. His ongoing work continues to shape best practices in post-chemotherapy retroperitoneal surgery, making him a key voice in the fight against germ cell tumours.